Viewing Study NCT07342920


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-31 @ 11:43 AM
Study NCT ID: NCT07342920
Status: RECRUITING
Last Update Posted: 2026-01-15
First Post: 2026-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Prevalence of Active/Passive Smoking and Vaping Among Patients With Cystic Fibrosis
Sponsor: University Hospital, Strasbourg, France
Organization:

Study Overview

Official Title: Study of the Prevalence of Active/Passive Smoking and Vaping Among Patients With Cystic Fibrosis
Status: RECRUITING
Status Verified Date: 2026-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Taba-Muco
Brief Summary: In the collective unconscious, a patient with cystic fibrosis does not smoke. This belief is so deeply rooted that there is virtually no French data on the prevalence of smoking among this vulnerable population.

Faced with a cohort of patients undergoing a complete transformation (improved quality of life and life expectancy, fewer hospitalizations, reduced respiratory symptoms, better social integration), it is becoming urgent to assess the current situation in order to optimize tobacco prevention.

This is all the more important given the emergence of international studies objectively examining the interactions between smoking, vaping, and the efficacy of Kaftrio.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: